These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

154 related items for PubMed ID: 3391643

  • 1. Mechanisms by which oxidative injury inhibits the proliferative response of human lymphocytes to PHA. Effect of the thiol compound 2-mercaptoethanol.
    Gougerot-Pocidalo MA, Fay M, Roche Y, Chollet-Martin S.
    Immunology; 1988 Jun; 64(2):281-8. PubMed ID: 3391643
    [Abstract] [Full Text] [Related]

  • 2. Immune oxidative injury induced in mice exposed to normobaric O2: effects of thiol compounds on the splenic cell sulfhydryl content and Con A proliferative response.
    Gougerot-Pocidalo MA, Fay M, Roche Y, Lacombe P, Marquetty C.
    J Immunol; 1985 Sep; 135(3):2045-51. PubMed ID: 4020138
    [Abstract] [Full Text] [Related]

  • 3. Thiol-mediated redox regulation of lymphocyte proliferation. Possible involvement of adult T cell leukemia-derived factor and glutathione in transferrin receptor expression.
    Iwata S, Hori T, Sato N, Ueda-Taniguchi Y, Yamabe T, Nakamura H, Masutani H, Yodoi J.
    J Immunol; 1994 Jun 15; 152(12):5633-42. PubMed ID: 8207197
    [Abstract] [Full Text] [Related]

  • 4. Effects of benzo[a]pyrene on concanavalin A-stimulated human peripheral blood mononuclear cells in vitro: inhibition of proliferation but no effect on parameters related to the G1 phase of the cell cycle.
    Mudzinski SP.
    Toxicol Appl Pharmacol; 1993 Apr 15; 119(2):166-74. PubMed ID: 8097600
    [Abstract] [Full Text] [Related]

  • 5. The extracts from Nelumbo Nucifera suppress cell cycle progression, cytokine genes expression, and cell proliferation in human peripheral blood mononuclear cells.
    Liu CP, Tsai WJ, Lin YL, Liao JF, Chen CF, Kuo YC.
    Life Sci; 2004 Jun 25; 75(6):699-716. PubMed ID: 15172179
    [Abstract] [Full Text] [Related]

  • 6. Changes in activation markers and cell membrane receptors on human peripheral blood T lymphocytes during cell cycle progression after PHA stimulation.
    Poulton TA, Gallagher A, Potts RC, Beck JS.
    Immunology; 1988 Jul 25; 64(3):419-25. PubMed ID: 3261709
    [Abstract] [Full Text] [Related]

  • 7. Rapamycin blocks cell cycle progression of activated T cells prior to events characteristic of the middle to late G1 phase of the cycle.
    Terada N, Lucas JJ, Szepesi A, Franklin RA, Domenico J, Gelfand EW.
    J Cell Physiol; 1993 Jan 25; 154(1):7-15. PubMed ID: 8419408
    [Abstract] [Full Text] [Related]

  • 8. A soluble factor from Trypanosoma brucei rhodesiense that prevents progression of activated human T lymphocytes through the cell cycle.
    Sztein MB, Kierszenbaum F.
    Immunology; 1991 Jun 25; 73(2):180-5. PubMed ID: 2071163
    [Abstract] [Full Text] [Related]

  • 9. Hypoxia affects cytokine production and proliferative responses by human peripheral mononuclear cells.
    Naldini A, Carraro F, Silvestri S, Bocci V.
    J Cell Physiol; 1997 Dec 25; 173(3):335-42. PubMed ID: 9369946
    [Abstract] [Full Text] [Related]

  • 10. Effect of the parasite enzyme, hypodermin A, on bovine lymphocyte proliferation and interleukin-2 production via the prostaglandin pathway.
    Nicolas-Gaulard I, Moire N, Boulard C.
    Immunology; 1995 May 25; 85(1):160-5. PubMed ID: 7635517
    [Abstract] [Full Text] [Related]

  • 11. IL-10 production is enhanced in human T cells by IL-12 and IL-6 and in monocytes by tumor necrosis factor-alpha.
    Daftarian PM, Kumar A, Kryworuchko M, Diaz-Mitoma F.
    J Immunol; 1996 Jul 01; 157(1):12-20. PubMed ID: 8683105
    [Abstract] [Full Text] [Related]

  • 12. Molecular basis of Trypanosoma cruzi-induced immunosuppression. Altered expression by activated human lymphocytes of molecules which regulate antigen recognition and progression through the cell cycle.
    Kierszenbaum F, Moretti E, Sztein MB.
    Biol Res; 1993 Jul 01; 26(1-2):197-207. PubMed ID: 7670532
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Mechanisms of inhibition of mononuclear cell activation by the iron-chelating agent desferrioxamine.
    Polson RJ, Jenkins R, Lombard M, Williams AC, Roberts S, Nouri-Aria K, Williams R, Bomford A.
    Immunology; 1990 Oct 01; 71(2):176-81. PubMed ID: 2228020
    [Abstract] [Full Text] [Related]

  • 15. Levamisole meets sulfhydryl requirements of CTLL-2 cells and mediates enhanced proliferative response to mitogen stimulation without increasing interleukin-2 production.
    Obiri NI, Dupere SL, Pruett SB, Lackey A, Emma D, O'Connor TE.
    J Biol Response Mod; 1990 Jun 01; 9(3):288-99. PubMed ID: 2380743
    [Abstract] [Full Text] [Related]

  • 16. Lymphokine regulation of activated (G1) lymphocytes. II. Glucocorticoid and anti-Tac-induced inhibition of human T lymphocyte proliferation.
    Bettens F, Kristensen F, Walker C, Schwuléra U, Bonnard GD, de Weck AL.
    J Immunol; 1984 Jan 01; 132(1):261-5. PubMed ID: 6606667
    [Abstract] [Full Text] [Related]

  • 17. Mechanisms of human T cell response to mitogens: IL 2 induces IL 2 receptor expression and proliferation but not IL 2 synthesis in PHA-stimulated T cells.
    Katzen D, Chu E, Terhost C, Leung DY, Gesner M, Miller RA, Geha RS.
    J Immunol; 1985 Sep 01; 135(3):1840-5. PubMed ID: 3926887
    [Abstract] [Full Text] [Related]

  • 18. [Effect of the tumor promoter TPA on the distribution of PHA-stimulated human lymphocytes by cell cycle phases].
    Vinogradov AE, Ezhevskiĭ IuM, Rozanov IuM, Kazhdan IIa, Tsveĭbakh AS.
    Tsitologiia; 1988 Aug 01; 30(8):983-90. PubMed ID: 3206545
    [Abstract] [Full Text] [Related]

  • 19. Intravenous immune globulin affects cytokine production in T lymphocytes and monocytes/macrophages.
    Andersson J, Skansén-Saphir U, Sparrelid E, Andersson U.
    Clin Exp Immunol; 1996 May 01; 104 Suppl 1():10-20. PubMed ID: 8625537
    [Abstract] [Full Text] [Related]

  • 20. Sodium arsenite retards proliferation of PHA-activated T cells by delaying the production and secretion of IL-2.
    Galicia G, Leyva R, Tenorio EP, Ostrosky-Wegman P, Saavedra R.
    Int Immunopharmacol; 2003 May 01; 3(5):671-82. PubMed ID: 12757736
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.